Please login to the form below

Not currently logged in
Email:
Password:

Juniper Pharmaceuticals adds to board of directors

Mary Ann Gray joins as audit committee chair

Juniper Mary Ann GrayBoston-based Juniper Pharmaceuticals has elected Mary Ann Gray to its board of directors and appointed her as its audit committee chair.

Dr Gray has over 20 years of biotechnology and biopharmaceutical experience and is the owner and president of Gray Strategic Advisors as well as serving on the boards of Acadia Pharmaceuticals, Senomyx Inc. and TetraLogic Pharmaceuticals.

Prior to its acquisition by Shire earlier this year, Dr Gray was lead director at Dyax Corporation and has also held senior roles at the Federated Kaufmann Fund, GTC Biotherapeutics and Schering-Plough.

Jim Geraghty, Juniper's chairman, said: “Mary Ann is a highly qualified corporate director and experienced audit committee chair, and we are very pleased to have her join Juniper's board.

“Her unique blend of Wall Street, financial, and scientific experience will be a tremendous asset as Juniper continues to advance its clinical programs to drive long-term shareholder value.”

Gray succeeds Donald Hunter, who tendered his resignation from the board last year.

Geraghty added: “We deeply appreciate Don Hunter's contributions during his tenure on Juniper's board, and his willingness to provide continuity in his role as audit committee chair during our extensive search for the right person to succeed him.” 

6th April 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
HAVAS LYNX

Welcome to HAVAS LYNX, a leading global healthcare communications group....

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics